Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
about
The primary health care physician and the cancer patient: tips and strategies for managing sexual healthEmotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancerThe Clinician's Toolbox: Assessing the Sexual Impacts of Cancer on Adolescents and Young Adults with Cancer (AYAC)Psychological correlates of sexual dysfunction in female rectal and anal cancer survivors: analysis of baseline intervention data.Creation of the Polish version and adaptation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (QLQ-EN24)Prevalence and correlates of sexual morbidity in long-term breast cancer survivorsBreast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapySexual dysfunction and infertility as late effects of cancer treatment.Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.Survivorship: sexual dysfunction (female), version 1.2013.Contemporary quality of life issues affecting gynecologic cancer survivors.A manifesto on the preservation of sexual function in women and girls with cancer.Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.The sexual health of female rectal and anal cancer survivors: results of a pilot randomized psycho-educational intervention trial.Body image and sexual function in women after treatment for anal and rectal cancer.Baseline characteristics and concerns of female cancer patients/survivors seeking treatment at a Female Sexual Medicine Program.Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014.Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.Efficacy trial of an Internet-based intervention for cancer-related female sexual dysfunctionSexual function, activity, and satisfaction among women receiving maintenance hemodialysis.Sexual health as a survivorship issue for female cancer survivors.A nurse-led sexual rehabilitation intervention after radiotherapy for gynecological cancerSexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index.Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?Rehabilitation interventions to improve patient-reported outcomes and physical fitness in survivors of muscle invasive bladder cancer: a systematic review protocol.Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors.Couple-based treatment for sexual problems following breast cancer: A review and synthesis of the literature.Associations of Body Mass Index and Physical Activity With Sexual Dysfunction in Breast Cancer Survivors.A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast's role in intimacy.Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis.Sexual health needs and educational intervention preferences for women with cancer.Validation of Clinical Tools for Vaginal and Vulvar Symptom Assessment in Cancer Patients and Survivors.Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision.Sexual function of women surviving cervical cancer.Sexual function in young women with type 1 diabetes: the METRO study.Sexual functioning in breast cancer survivors experiencing body image disturbance.Fertility and sexual function in female Hodgkin lymphoma survivors of reproductive age.What Happens After Menopause? (WHAM): protocol for a prospective, multicentre, age-matched cohort trial of risk-reducing bilateral salpingo-oophorectomy in high-risk premenopausal women.
P2860
Q26773683-BBCCB729-F6F1-405B-BB0A-28D493206D1DQ26773707-CA93112B-B182-4284-A1C4-925526054B0EQ26782823-700CB3F7-8A0F-47FA-A7B0-46A5E0DC3079Q30611540-21F8AFEA-6E3E-44FE-8830-D8651142A1EAQ33799256-E9433426-A34D-4DEF-9DFC-496AAC537C5AQ33922545-E8EA8192-0596-42BC-90A9-F5975AAEFEECQ34286594-7F268DB1-52BE-403C-AFC2-0FC370178230Q34604454-E514BADA-5ADB-48A5-AF57-6876B3C82E92Q35007815-82FE5CE5-CD93-4DF0-86DF-046046D7E1FBQ35207952-A6E82F26-14D4-4229-81B5-D5740E5291BBQ35735025-6E81CA87-7FA7-4761-9D6C-4B779C2F8DC7Q36067725-B5AA3D29-48AA-4BFE-9CD4-6D6BDF6589C6Q36407045-D24BEB39-93FD-407E-B7D3-65AD3916665BQ36810368-653AF2C2-7A93-4A87-87A5-86DDB5200EA1Q36892660-D9439F9A-C034-4718-BFA1-70A3C6130E8FQ37126400-762A245F-DA35-4FD1-8734-1C71202EC73DQ37163473-C2EB9E28-B536-45AC-A94C-9ACB6DA20CF3Q37193477-DC2E54F9-4BB3-4766-9782-98D9EE5D90C7Q37298737-2A7C7B54-ECEF-4469-AA6A-B55414AD22C6Q37317353-C6260E8F-B4F3-428C-8CBE-00BCD77A06E1Q37426970-C5DA44E1-73C5-4C7E-8BAE-DE2F06128D88Q37589056-A088CD4C-50E7-49AA-849B-851E32B59273Q37607272-AA97BD6B-9E67-4D19-B4B4-58591188D285Q38661411-C2D1B68E-6D2B-4792-B1E2-5645D29A5E27Q38728442-5E1101DE-7C52-46B3-9AAC-AA175E213841Q38737525-C4C5113B-EF6F-4F60-B951-76EE4E6B144CQ38792918-3E530A9E-D09D-4C0E-BB70-886C45882A99Q38827786-CDA5508B-6518-4552-9786-666520373299Q38858318-B82933B6-EBAE-4992-A54C-AF66D40B27D6Q38947105-73669580-0520-4D72-B61D-FEE79A178F2BQ39161841-07B4EC63-DFB5-4B36-B5A0-5FEBD1F285D0Q39511288-C39CDB6D-ECE2-4153-9340-F575E58B6E7AQ40184404-506E0C76-BF07-4D83-943E-717190470D07Q40409779-2F4E46D1-6315-4A9E-94EB-0BB5EA127994Q40513982-116C5C09-38E0-4A10-B86E-3565A82D9E9EQ40579177-A0B5C713-C6AD-4181-B2EA-A14F91BAFFD9Q40587413-36A44FEF-B3BF-4058-A78C-2C15A15B3C4CQ41008896-A771B4E6-F5E8-4A20-94DA-0B582226B0DBQ45898041-0967E231-38AF-4F2A-A9AE-2CFB692E9F97Q47127058-C518FC32-6BBE-4701-B4EA-CA2F02DC2A67
P2860
Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
@en
Psychometric validation of the Female Sexual Function Index
@nl
type
label
Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
@en
Psychometric validation of the Female Sexual Function Index
@nl
prefLabel
Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
@en
Psychometric validation of the Female Sexual Function Index
@nl
P2093
P2860
P356
P1433
P1476
Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.
@en
P2093
Jeanne Carter
Raymond E Baser
P2860
P304
P356
10.1002/CNCR.26739
P407
P577
2012-02-22T00:00:00Z